4//SEC Filing
Growth Equity Opportunities IV, LLC 4
Accession 0001209191-18-047958
CIK 0001325879other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 4:42 PM ET
Size
10.2 KB
Accession
0001209191-18-047958
Insider Transaction Report
Form 4
NEA 15 GP, LLC
10% Owner
Transactions
- Purchase
Common Stock
2018-08-21$2.26/sh+663,716$1,499,998→ 18,698,038 total
New Enterprise Associates 15, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2018-08-21$2.26/sh+663,716$1,499,998→ 18,698,038 total
NEA Partners 15, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2018-08-21$2.26/sh+663,716$1,499,998→ 18,698,038 total
Growth Equity Opportunities IV, LLC
10% Owner
Transactions
- Purchase
Common Stock
2018-08-21$2.26/sh+663,716$1,499,998→ 18,698,038 total
Footnotes (2)
- [F1]The shares are directly held by Growth Equity Opportunities Fund IV, LLC ("GEO IV") and indirectly held by New Enterprise Associates 15, L.P. ("NEA 15"), the sole member of GEO IV, NEA Partners 15, L.P. ("NEA Partners 15"), the sole general partner of NEA 15, NEA 15 GP, LLC ("NEA 15 GP"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA 15, NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP, together, the "Indirect Reporting Persons").
- [F2]The individual managers of NEA 15 GP are Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Josh Makower, David M. Mott, Scott D. Sandell, Peter W. Sonsini and Ravi Viswanathan. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares of the Issuer held by GEO IV in which the Indirect Reporting Persons have no pecuniary interest.
Documents
Issuer
AVEO PHARMACEUTICALS INC
CIK 0001325879
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001644965
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 4:42 PM ET
- Size
- 10.2 KB